Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Fight Against Multidrug-Resistant Bacteria.
Deak D, Powers JH, Outterson K, Kesselheim AS. Deak D, et al. Ann Intern Med. 2017 Jan 3;166(1):79. doi: 10.7326/L16-0582. Ann Intern Med. 2017. PMID: 28030672 No abstract available.
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis.
Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, Pulcini C, Kahlmeter G, Kluytmans J, Carmeli Y, Ouellette M, Outterson K, Patel J, Cavaleri M, Cox EM, Houchens CR, Grayson ML, Hansen P, Singh N, Theuretzbacher U, Magrini N; WHO Pathogens Priority List Working Group. Tacconelli E, et al. Lancet Infect Dis. 2018 Mar;18(3):318-327. doi: 10.1016/S1473-3099(17)30753-3. Epub 2017 Dec 21. Lancet Infect Dis. 2018. PMID: 29276051
Introduction and geographic availability of new antibiotics approved between 1999 and 2014.
Kållberg C, Årdal C, Salvesen Blix H, Klein E, M Martinez E, Lindbæk M, Outterson K, Røttingen JA, Laxminarayan R. Kållberg C, et al. Among authors: outterson k. PLoS One. 2018 Oct 16;13(10):e0205166. doi: 10.1371/journal.pone.0205166. eCollection 2018. PLoS One. 2018. PMID: 30325963 Free PMC article.
Approval and withdrawal of new antibiotics and other antiinfectives in the U.S., 1980-2009.
Outterson K, Powers JH, Seoane-Vazquez E, Rodriguez-Monguio R, Kesselheim AS. Outterson K, et al. J Law Med Ethics. 2013 Fall;41(3):688-96. doi: 10.1111/jlme.12079. J Law Med Ethics. 2013. PMID: 24088160
Repairing the broken market for antibiotic innovation.
Outterson K, Powers JH, Daniel GW, McClellan MB. Outterson K, et al. Health Aff (Millwood). 2015 Feb;34(2):277-85. doi: 10.1377/hlthaff.2014.1003. Health Aff (Millwood). 2015. PMID: 25646108
Towards new business models for R&D for novel antibiotics.
So AD, Gupta N, Brahmachari SK, Chopra I, Munos B, Nathan C, Outterson K, Paccaud JP, Payne DJ, Peeling RW, Spigelman M, Weigelt J. So AD, et al. Drug Resist Updat. 2011 Apr;14(2):88-94. doi: 10.1016/j.drup.2011.01.006. Epub 2011 Mar 25. Drug Resist Updat. 2011. PMID: 21439891 Review.
Antimicrobial Resistance: The Authors Reply.
Outterson K, McDonnell A. Outterson K, et al. Health Aff (Millwood). 2016 Oct 1;35(10):1936. doi: 10.1377/hlthaff.2016.1106. Health Aff (Millwood). 2016. PMID: 27702975 No abstract available.
International cooperation to improve access to and sustain effectiveness of antimicrobials.
Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, Smith R, Zorzet A, Cohn J, Pittet D, Daulaire N, Morel C, Rizvi Z, Balasegaram M, Dar OA, Heymann DL, Holmes AH, Moore LS, Laxminarayan R, Mendelson M, Røttingen JA. Årdal C, et al. Lancet. 2016 Jan 16;387(10015):296-307. doi: 10.1016/S0140-6736(15)00470-5. Epub 2015 Nov 18. Lancet. 2016. PMID: 26603920 Review.
What Will It Take to Address the Global Threat of Antibiotic Resistance?
Hoffman SJ, Outterson K. Hoffman SJ, et al. J Law Med Ethics. 2015 Summer;43(2):363-8. doi: 10.1111/jlme.12253. J Law Med Ethics. 2015. PMID: 26242959
50 results
Jump to page
Feedback